Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Menorrhagia × Radiofrequency Ablation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 36 Neoplasm Metastasis 17 Liver Neoplasms 16 Colorectal Neoplasms 13 Cholangiocarcinoma 11 Lung Neoplasms 9 Pancreatic Neoplasms 8 Colonic Neoplasms 8 Carcinoma, Non-Small-Cell Lung 7 Breast Neoplasms 7 Barrett Esophagus 7 Thyroid Nodule 6 Recurrence 5 Rectal Neoplasms 5 Carcinoma, Renal Cell 5 Thyroid Neoplasms 4 Pain 4 Neoplasms 4 Esophageal Neoplasms 4 Prostatic Neoplasms 3 Leiomyoma 3 Kidney Neoplasms 3 Biliary Tract Neoplasms 3 Bile Duct Neoplasms 3 Agnosia 3 Thyroid Diseases 2 Thyroid Cancer, Papillary 2 Hyperaldosteronism 2 Gallbladder Neoplasms 2 Cancer Pain 2

Interventions

estradiol, norethindrone drug combination 6 elagolix 6 asoprisnil 6 Uterine Artery Embolization 6 Estradiol 5 vilaprisan 4 Uterine Myomectomy 4 Norethindrone Acetate 4 relugolix 3 linzagolix 2 Tranexamic Acid 2 ziprasidone 1 ulipristal acetate 1 ulipristal 1 pycnogenols 1 Zolpidem 1 Warfarin 1 Vecuronium Bromide 1 Vancomycin 1 Tobramycin 1 Spironolactone 1 Sevelamer 1 Rocuronium 1 Radiofrequency Ablation 1 Piperacillin, Tazobactam Drug Combination 1 Pentobarbital 1 Oxycodone 1 Nifedipine 1 Nafcillin 1 Molindone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02163525 2025-09-30

Post Market TRUST - U.S.A. Study

Acessa Health, Inc.

Phase NA Completed

Leiomyoma, Menorrhagia, Myoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡